|
MGC16142 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.02780001071312E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.72599737122437E-12 |
| Normal-vs-Stage2 |
9.198300E-03 |
| Normal-vs-Stage3 |
3.818700E-03 |
| Normal-vs-Stage4 |
9.377700E-04 |
| Stage1-vs-Stage2 |
5.336400E-02 |
| Stage1-vs-Stage3 |
4.161500E-04 |
| Stage1-vs-Stage4 |
8.062600E-03 |
| Stage2-vs-Stage3 |
5.572000E-01 |
| Stage2-vs-Stage4 |
8.510800E-01 |
| Stage3-vs-Stage4 |
6.292000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.09550002192327E-09 |
| Normal-vs-AfricanAmerican |
8.864300E-03 |
| Normal-vs-Asian |
1.822490E-02 |
| Caucasian-vs-AfricanAmerican |
3.190200E-01 |
| Caucasian-vs-Asian |
1.558200E-02 |
| AfricanAmerican-vs-Asian |
1.624340E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.26939999622877E-08 |
| Normal-vs-Female |
8.80079999987515E-08 |
| Male-vs-Female |
8.537600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.645560E-02 |
| Normal-vs-Age(41-60Yrs) |
2.13310002994405E-09 |
| Normal-vs-Age(61-80Yrs) |
9.34520000273054E-08 |
| Normal-vs-Age(81-100Yrs) |
9.624800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.786800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.374200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.489500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.134200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.404200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.376300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.28660000001213E-06 |
| Normal-vs-Grade 2 |
5.19451148761618E-12 |
| Normal-vs-Grade 3 |
1.85487999999623E-05 |
| Normal-vs-Grade 4 |
2.663600E-02 |
| Grade 1-vs-Grade 2 |
4.100600E-01 |
| Grade 1-vs-Grade 3 |
2.683500E-02 |
| Grade 1-vs-Grade 4 |
4.504300E-03 |
| Grade 2-vs-Grade 3 |
8.229600E-04 |
| Grade 2-vs-Grade 4 |
8.31460000000339E-05 |
| Grade 3-vs-Grade 4 |
1.651040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.54791801177635E-15 |
| Normal-vs-ccB subtype |
2.044600E-03 |
| ccA subtype-vs-ccB subtype |
1.62560000016576E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91199999999281E-06 |
| Normal-vs-N1 |
7.428300E-02 |
| N0-vs-N1 |
8.361000E-01 |
|
|
